Instituto Tecnológico Superior de Teziutlán | Mexico

Author Profile

Early Academic Pursuits 📚

Dr. Mayra Nicolás García began her academic journey with a Bachelor’s Degree in Biochemical Engineering with a specialty in Food from the Tuxtepec Technological Institute (2008-2012). Her interest in food science led her to pursue a Master's Degree in Food Science at the same institution. Her thesis focused on the physicochemical characterization and sensory evaluation of vanilla extracts, guided by Dr. Araceli Pérez Silva. She furthered her studies with a Doctorate in Food Sciences from the National School of Biological Sciences, National Polytechnic Institute (2017-2021), where she explored the aromatic characteristics of vanilla fruit.

Professional Endeavors 🔬

Dr. Nicolás García's professional career is marked by significant contributions to food science and engineering. She has worked at various institutions, including the Tecnológico de Estudios Superiores de San Felipe del Progreso and the Tuxtepec Technological Institute. Her roles have encompassed teaching, research, and project management. Her research stay at CIRAD-Université de La Réunion and her participation in multiple research projects have enhanced her expertise in food science, particularly in the extraction and characterization of bioactive compounds.

Contributions and Research Focus 🔍

Dr. Nicolás García's research focuses on the extraction and analysis of bioactive compounds from various food sources, including vanilla and mango. Her work involves the use of advanced chromatographic techniques to identify and quantify bioactive compounds and assess their functional properties. She has published extensively on topics such as the micromechanical analysis of food structures, the impact of post-harvest storage on food quality, and the valorization of agro-industrial waste. Her research also delves into the functional and nutraceutical properties of foods, with a keen interest in improving food safety and quality.

Accolades and Recognition 🏅

Dr. Nicolás García has received recognition for her contributions to food science and technology. She holds a Level I position in the National System of Researchers (SNII) and has been involved in various funded research projects. Her work has been acknowledged through multiple publications in high-impact journals and book chapters. She has also been active in scientific dissemination, contributing to the advancement of food science through both research and teaching.

Impact and Influence 🌟

Dr. Nicolás García's impact extends beyond her research contributions. Her work on the characterization of bioactive compounds and the evaluation of food quality has influenced practices in food processing and safety. Her involvement in academic programs and research projects has helped shape the curriculum and research focus at her institutions. Her contributions to the field of food science and engineering continue to inspire and guide future research and development in the industry.

Legacy and Future Contributions 🔮

As Dr. Nicolás García advances in her career, her focus on bioactive compounds and food safety remains pivotal. Her future contributions are likely to further enhance the understanding and application of functional foods and the management of food resources. Her ongoing projects and research are expected to continue impacting the field of food science, fostering innovations that address global challenges in food safety and quality.

Publications 📚

📝 Effect of post-harvest storage on the chemical and microstructural characteristics of the common bean (Phaseolus vulgaris L.)
Authors: Nicolás-García, M., Perucini-Avendaño, M., Perea-Flores, M.D.J., Camacho-Díaz, B.H., Dávila-Ortiz, G.
Journal: Food Chemistry
Year: 2024

📝 Effect of cooking on structural changes in the common black bean (Phaseolus vulgaris var. Jamapa)
Authors: Perucini-Avendaño, M., Arzate-Vázquez, I., Perea-Flores, M.D.J., Nicolás-García, M., Dávila-Ortiz, G.
Journal: Heliyon
Year: 2024

📝 Nanosuspensions as carriers of active ingredients: Chemical composition, development methods, and their biological activities
Authors: Aguilar-Hernández, G., López-Romero, B.A., Nicolás-García, M., García-Galindo, H.S., Montalvo-González, E.
Journal: Food Research International
Year: 2023

📝 Phenolic Compounds in Agro-Industrial Waste of Mango Fruit: Impact on Health and Prebiotic Effect – a Review
Authors: Nicolás-García, M., Borrás-Enríquez, A.J., González-Escobar, J.L., Pérez-Pérez, V., Sánchez-Becerril, M.
Journal: Polish Journal of Food and Nutrition Sciences
Year: 2023

📝 Phenolic compounds profile by UPLC-ESI-MS in black beans and its distribution in the seed coat during storage
Authors: Nicolás-García, M., Perucini-Avendaño, M., Arrieta-Báez, D., Beatriz Gómez-Patiño, M., Dávila-Ortiz, G.
Journal: Food Chemistry
Year: 2022

Thiruchelvi R | Engineering | Young Scientist Award

Posted on 09/08/202409/08/2024 by Book of Award

Mrs. Thiruchelvi R | Engineering | Young Scientist Award

St.Jospehs College of Engineering | India

Author profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Mrs. Thiruchelvi R's academic journey began at John Bosco Matriculation Higher Secondary School in Kovilpatti, where she completed her SSLC in May 2004 with an impressive 85% score. She continued her education at St. Pauls Matriculation Higher Secondary School, where she pursued Mathematics and Biology, achieving 82% in her HSC in May 2006. Her passion for biotechnology led her to pursue a B.Tech in Biotechnology at P.S.R. Engineering College, Sivakasi, under Anna University, Chennai, graduating in May 2010 with a remarkable 86% CGPA. She further honed her expertise with an M.Tech in Biotechnology from Kamaraj College of Engineering and Technology, Virudhunagar, where she excelled with a 9.2 CGPA in May 2012. Currently, she is pursuing her Ph.D. in Biotechnology at St. Joseph College of Engineering and Technology, Chennai, under Anna University, set to complete in November 2025.

💼 Professional Endeavors

Mrs. Thiruchelvi embarked on her professional journey as an Assistant Professor at Vels Institute of Science Technology and Advanced Studies (VISTAS), serving from July 2017 to April 2023. Her role as a Senior Research Technical Consultant at Aman Aqua Bio Chemical, focusing on chemical-free plant activators, further solidified her position as a leading researcher. Since May 2023, she has been contributing her expertise in India and Abu Dhabi.

🧬 Contributions and Research Focus

Mrs. Thiruchelvi's research interests are deeply rooted in Marine Biotechnology, Nanobiotechnology, and the valorization of fruit waste for value-added products. Her technical skills encompass a wide array of expertise, from the extraction and characterization of biological compounds from macroalgae and fruit waste to enzyme kinetics and drug design. Her work in optimizing methodologies and supervising interdisciplinary research projects has been instrumental in advancing biotechnology applications.

🏆 Accolades and Recognition

Mrs. Thiruchelvi's contributions have been recognized with numerous awards, including the prestigious Young Women Tech Innovator Award in April 2023 and the Academic Achiever Award in March 2023. Her achievements also include the Best Woman Scientist Award in September 2022 and the Best Woman Award for Excellence and Innovation in April 2022. Her accolades reflect her dedication and innovation in the field of biotechnology.

🌍 Impact and Influence

Through her extensive research and development work, Mrs. Thiruchelvi has made significant strides in providing sustainable solutions for the bioenergy industry. Her expertise in macroalgae cultivation, enzyme kinetics, and drug design has not only contributed to academic knowledge but also to practical applications that benefit society. Her role in mentoring students and guiding research projects has left a lasting impact on the next generation of scientists.

🏅 Legacy and Future Contributions

As Mrs. Thiruchelvi continues her research and academic endeavors, her legacy is set to grow. Her contributions to biotechnology, particularly in sustainable biomass supply and marine biotechnology, are paving the way for future innovations. Her dedication to teaching, research, and industry collaboration ensures that her influence will extend far beyond her immediate work, inspiring future researchers and contributing to the global scientific community.

Publications 📚

📜In Silico Studies of the Hepatitis B Viral Protein for Drug Discovery
Authors: Arun, S.P. , Thiruchelvi, R. , Rajakumari, K.
Journal: Oxidation Communications
Year: 2023

📜Nanotheranostics for Cancer Therapy and Detection: Strategies, Promises, and Impediments
Authors: Jacqulyn, V. , Priya, S.L. , Thiruchelvi, R. , Rajakumari, K.
Journal: Oxidation Communications
Year: 2023

📜Chitosan Nanoparticle Encapsulated with Terminalia chebula – In Vitro Antidiabetic Activity
Authors: Nath, R. , Rajakumari, K. , Thiruchelvi, R. , Ivo Romauld, S. , Vivek, P.
Journal: Oxidation Communications
Year: 2023

📜Collagen – Zinc Oxide Nanoparticles (ZnO NPs) Composites for Wound Healing – A Review
Authors: Thiruchelvi, R. , Priyadharshini, S. , Mugunthan, P. , Rajakumari, K.
Journal: Research Journal of Pharmacy and Technology
Year: 2022

📜The Phytochemical Components of Caesalpinia Sappan in Treating Respiratory Ailments Through an Herbal Soup in Addition with Sensory Evaluation
Authors: Moyeenudin, H.M. , Thiruchelvi, R. , Wilfred Lawrence, A. , John Williams, R.
Journal: Materials Today: Proceedings
Year: 2022

Kercia Cruz | Agricultural and Biological Sciences | Best Researcher Award

Posted on 03/08/202403/08/2024 by Book of Award

Dr. Kercia Cruz | Agricultural and Biological Sciences | Best Researcher Award

Federal University of Bahia | Brazil

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Kercia Cruz began her academic journey with a degree in Biological Sciences from Universidade Federal da Bahia in 2014. She furthered her studies with a master’s in Biotechnology in Health and Investigative Medicine from Fundação Oswaldo Cruz, graduating in 2017. Her research during this period focused on leishmaniasis and the role of macrophages in infection. She then pursued a Ph.D. in Biotechnology in Health and Investigative Medicine at Fundação Oswaldo Cruz, completing it in 2023. Her doctoral research centered on the development of nanomedicines for treating leishmaniasis, particularly focusing on the protein translocator HSP90.

Professional Endeavors 🔬

Dr. Cruz has worked extensively in the field of general biology with a specialization in leishmaniasis and macrophage infections. Her professional experience includes positions at Universidade Federal da Bahia and Centro Universitário SENAI CIMATEC, where she has contributed significantly to research and education. Her roles involved working on projects related to the therapeutic potential of nanoparticles and the molecular mechanisms of leishmaniasis. She has also participated in various internships and short-term research activities across Brazil and Portugal. 🌍

Contributions and Research Focus 🧫

Dr. Cruz’s research primarily focuses on leishmaniasis, particularly the use of nanomedicines and the role of protein translocators like HSP90 in combating infection. She has been involved in several research projects exploring the potential of nanoparticle-based therapies for leishmaniasis and other infectious diseases. Her work also includes studying the molecular and cellular aspects of macrophage interactions with pathogens, contributing to the development of innovative treatment strategies. 🧪

Accolades and Recognition 🏅

Dr. Cruz has received notable recognition for her research contributions. In 2022, she was awarded an honorable mention for her work on polymeric nanoparticles containing amphotericin B at Embrapa. Additionally, she received a commendation in 2020 for her ongoing doctoral thesis from the Program of Postgraduate Studies in Biotechnology in Health and Investigative Medicine at Fiocruz. These accolades highlight her significant impact in her field. 🏆

Impact and Influence 🌟

Dr. Cruz’s research has advanced the understanding of leishmaniasis and the potential of nanomedicines in treating this disease. Her work on nanomedicine and protein translocators has provided valuable insights into innovative treatment approaches, potentially improving patient outcomes and contributing to global health solutions. Her contributions have influenced both academic research and practical applications in biotechnology. 🌐

Legacy and Future Contributions 🚀

Looking forward, Dr. Cruz aims to continue her work on developing novel therapeutic strategies for infectious diseases. Her future research will likely focus on expanding the use of nanomedicines and exploring new avenues in molecular biology to address pressing health challenges. Her dedication to advancing scientific knowledge and improving treatment options ensures that her legacy will continue to benefit the field of biotechnology and beyond.

Publications 📚

📝Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Leishmania braziliensis Infection in BALB/c Mice: A Preclinical Study
- Authors: Kercia P. Cruz, Antonio L. O. A. Petersen, Marina F. Amorim, Alan G. S. F. Pinho, Luana C. Palma, Diana A. S. Dantas, Mariana R. G. Silveira, Carine S. A. Silva, Ana Luiza J. Cordeiro, Izabella G. Oliveira, Gabriella B. Pita, Bianca C. A. Souza, Gilberto C. Bomfim, Cláudia I. Brodskyn, Deborah B. M. Fraga, Isadora S. Lima, Maria B. R. De_Santana, Helena M. P. Teixeira, Juliana P. B. De_Menezes, Washington L. C. Santos
- Journal: Pathogens
- Year: 2024

📝Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor
- Authors: Kercia P. Cruz, Beatriz F. C. Patricio, Vinícius C. Pires, Marina F. Amorim, Alan G. S. F. Pinho, Helenita C. Quadros, Diana A. S. Dantas, Marcelo H. C. Chaves, Fabio R. Formiga, Helvécio V. A. Rocha, Patrícia S. T. Veras
- Journal: Frontiers in Chemistry
- Year: 2021

📝Microbiologia no cotidiano: proposta de ensino por investigação de baixo custo
- Authors: K. P. Cruz, G. L. Nery, A. A. D. Reboucás, P. R. Dantas-Silva, J. S. Cruz, C. G. S. Andrade, R. M. L. Rahimy
- Journal: Atas de Ciências da Saúde
- Year: 2019

📝In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
- Authors: C. E. S. Guedes, B. R. S. Dias, A. L. O. A. Petersen, Kercia P. Cruz, N. J. Almeida, D. R. Andrade, J. P. B. Menezes, V. M. Borges, P. S. T. Veras
- Journal: Memórias do Instituto Oswaldo Cruz
- Year: 2018

Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 03/08/202403/08/2024 by Book of Award

Dr. Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Maastricht University | Netherlands

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Fang Wang's academic journey began with a Bachelor’s degree in Pharmacology from Nanchang University, where she developed an oxidative stress model in LO2 cells to test stress amelioration compounds. She continued her studies with a Master's degree in Cell Biology at the same university, focusing on the role of progesterone adiponectin receptor 7 in reproduction and differences in protein post-translational modifications. Currently, she is pursuing a PhD in Cell Biology at Maastricht University, investigating substrate metabolism in diabetic cardiomyopathy and novel treatments using bioactive components from Traditional Chinese Medicine.

Professional Endeavors 🔬

With over seven years of experience, Dr. Wang has built a strong foundation in preclinical research, drug development, scientific communication, and project management. Her professional career includes internships at Shanghai ChemPartner Co., Ltd. and Jiangxi Zhby Biotech Co. Ltd., where she gained hands-on experience in molecular biology testing and research planning. Her current roles involve significant contributions to research in metabolic disorders and male infertility, with a focus on protein translocation and endosome pH regulation.

Contributions and Research Focus 🌟

Dr. Wang’s research primarily targets the intersection of metabolic disorders and drug development, specifically focusing on diabetic cardiomyopathy and the impact of Traditional Chinese Medicine on cardiac health. Her work includes investigating novel treatment strategies and exploring the mechanisms of substrate metabolism, protein translocation, and endosome pH regulation. Her expertise spans a wide range of molecular and cell biology techniques, including advanced imaging and bioinformatics.

Accolades and Recognition 🏆

Dr. Wang has made notable contributions to the field through her publications and presentations at various conferences. Her research on lipid-induced contractile dysfunction and diabetic cardiomyopathy has been recognized in leading journals and upcoming publications. Her work is highly regarded in the scientific community, reflecting her commitment to advancing healthcare solutions.

Impact and Influence 🌍

Dr. Wang's research has a profound impact on understanding and treating metabolic disorders, particularly in diabetic cardiomyopathy. Her innovative approaches and exploration of traditional medicine offer promising solutions for improving patient outcomes and advancing the field of metabolic disease research. Her contributions are shaping new therapeutic strategies and enhancing the quality of life for patients.

Legacy and Future Contributions 🚀

Dr. Wang's future endeavors are set to further explore and develop cutting-edge healthcare solutions. Her ongoing research aims to refine treatment strategies for metabolic disorders and improve the efficacy of drug development. By integrating advanced techniques and traditional medicine, she is poised to make significant strides in the field, contributing to a healthier future and advancing scientific knowledge.

Publications 📕

📝 Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes
- Authors: Fang Wang, Dietbert Neumann, Dimitrios Kapsokalyvas, Martijn Hoes, Francesco Schianchi, Jan Glatz, Miranda Nabben, Joost J. F. P. Luiken
- Journal: International Journal of Molecular Sciences
- Year: 2024

📝 Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
- Authors: Shujin Wang, Han YinYing, Ruimin Liu, Hou M, Dietbert Neumann, Jun Zhang, Wang F, Yumeng Li, Zhao X, Francesco Schianchi et al.
- Journal: Circulation Research
- Year: 2024

📝 Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice
- Authors: Li J, Liu Y, He J, Wu Z, Wang F, Huang J, Zheng L, Luo T
- Journal: Journal of Ovarian Research
- Year: 2024

📝 CD36 as a target for metabolic modulation therapy in cardiac disease
- Authors: Glatz JFC, Wang F, Miranda Nabben, Luiken JJFP
- Journal: Expert Opinion on Therapeutic Targets
- Year: 2021

📝 Diet-induced obesity is associated with altered expression of sperm motility-related genes and testicular post-translational modifications in a mouse model
- Authors: Wang F, Chen H, Chen Y, Cheng Y, Li J, Zheng L, Zeng X, Luo T
- Journal: Theriogenology
- Year: 2020

Dong Hee Kim | Biochemistry, Genetics and Molecular Biology | Best Research Award

Posted on 03/08/202403/08/2024 by Book of Award

Dr. Dong Hee Kim | Biochemistry, Genetics and Molecular Biology | Best Research Award

Pusan national university | South Korea

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Dong Hee Kim began his academic journey with a Bachelor of Science in Biology from the University of Ulsan, Korea, in 2004. He continued at the same institution for his M.S.-Ph.D. in Biological Sciences under the mentorship of Professor Byung Ju Lee, completing his doctorate in 2012. His thesis, "Studies on the role of NELL2 in neuroprotection and neural differentiation," laid the foundation for his future research endeavors.

💼 Professional Endeavors

Dr. Kim has held various prestigious positions throughout his career. He is currently a Research Fellow at Pusan National University Hospital since November 2022. Previously, he served as a Research Professor at the University of Ulsan from January 2019 to May 2022, and as a Research Fellow at the same university from January 2015 to October 2016. His early postdoctoral work was conducted at UNIST from March 2013 to December 2014.

🧪 Contributions and Research Focus

Dr. Kim's research primarily revolves around neuroprotection, neural differentiation, and the molecular mechanisms underlying neurodegenerative diseases. His notable grants include funding from WISET for studying the function of sodium-glucose cotransporter 2 (SGLT2) inhibitors in the brain, and multiple grants from the NRF of Korea, including studies on TonEBP function in hypothalamic leptin resistance and its role in degenerative brain disorders.

🏅 Accolades and Recognition

Throughout his career, Dr. Kim has received significant recognition for his contributions to biomedical research. His projects have been supported by prestigious grants, highlighting the impact and importance of his work in understanding brain functions and disorders. His research has also resulted in numerous publications in high-impact journals, further establishing his reputation in the field.

🌟 Impact and Influence

Dr. Kim's research has significantly advanced the understanding of neural mechanisms and their implications in neurodegenerative diseases. His work on the transcription regulation of key genes involved in brain function and inflammation has provided new insights into potential therapeutic targets. His publications have been widely cited, indicating the influence of his research on the scientific community.

📚 Legacy and Future Contributions

Dr. Kim's ongoing research continues to push the boundaries of our understanding of the brain. His current projects, funded by substantial grants, promise to uncover new mechanisms of brain function and disease. As he progresses in his career, Dr. Kim is poised to make further groundbreaking discoveries that will contribute to the field of biomedical science and technology.

Publications 📘

📄 Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Transcription Regulation of AgRP and POMC Genes

👩‍🔬 Authors: Kim DH*, Lee MJ, Kang D, Khang AR, Bae JH, Kim JY, Kim SH, Kang YH, Yi D.

📕 Journal: Curr Issues Mol Biol.

📅 Year: 2024

📄 Bridging Energy Need and Feeding Behavior: The Impact of eIF2α Phosphorylation in AgRP Neurons

👩‍🔬 Authors: Kim KK, Lee TH, Park BS, Kang D, Kim DH, Jeong B, Kim JW, Yang HR, Kim HR, Jin S, Back SH, Park JW, Kim JG, Lee BJ.

📕 Journal: Diabetes

📅 Year: 2023

📄 Sirtuin 1-Mediated Deacetylation of Hypothalamic TTF-1 Contributes to Energy Deficiency Response

👩‍🔬 Authors: Kang D, Yang HR, Kim DH, Kim KK, Jeong B, Park BS, Park JW, Kim JG, Lee BJ.

📕 Journal: Int J Mol Sci.

📅 Year: 2023

📄 Inhibition of LPAR1 Signaling in PDLSCs Reduces the Inflammatory Paracrine Effect on Primary Astrocyte Cells

👩‍🔬 Authors: Kim DH*, Seo EJ*, Kim YH, Jang IH.

📕 Journal: Int J Oral Biol.

📅 Year: 2022

📄 Transcriptional Regulatory Role of NELL2 in Preproenkphalin Gene Expression

👩‍🔬 Authors: Ha CM*, Kim DH*, Lee TH, Kim HR, Choi JI, Kim Y, Kang DS, Park JW, Oieda S, Jeong JK, Lee BJ.

📕 Journal: Mol Cells

📅 Year: 2022

Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on 23/07/202423/07/2024 by Book of Award

Prof Dr. Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Anadolu University | Turkey

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Ahmet Özdemir's academic journey began at Salihli Cumhuriyet Elementary School (1978-1983), followed by Salihli 50. Yıl Secondary School (1983-1986) and Salihli High School (1986-1989). His passion for pharmacy led him to Anadolu University Faculty of Pharmacy, where he completed his undergraduate studies (1990-1994). He pursued further education at the Graduate School of Health Sciences, Department of Pharmaceutical Chemistry at Anadolu University, earning a Master's degree (1995-1996) and a Doctor's degree (1996-2004).

Professional Endeavors 💼

Prof. Dr. Özdemir's professional career commenced at Anadolu University as a Research Assistant (1997-2004). He progressed to Research Assistant Doctor (2004-2005), Lecturer (2005-2007), and Assistant Professor Doctor (2007-2010). His dedication and expertise earned him the title of Associate Professor Doctor (2010-2015), and he has been serving as a Professor Doctor since 2015.

Contributions and Research Focus 🔍

Prof. Dr. Özdemir's research is marked by significant contributions to pharmaceutical chemistry. His Master's thesis focused on "The studies on the synthesis, structure elucidations and determination of physicochemical parameters of some 2-substituted-1H-phenantro[9,10-d]imidazole compounds," under the supervision of Prof. Dr. İlhan Işıkdağ. His PhD thesis, supervised by Prof. Dr. Gülhan Turan, investigated the "Synthesis of some 1-[(N,N-disubstituted-thiocarbonylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and their antifungal, antibacterial activities."

Accolades and Recognition 🏅

Prof. Dr. Özdemir's work has been widely recognized, earning him numerous awards:

Anadolu University Article Performance Award (2014, 2016, 2017, 2018, 2020)
Anadolu University Gold Article Performance Award (2015)
Anadolu University Platinum Article Performance Award (2015)
Anadolu University Academic Success Award (2019)
ISIF'21 Silver Medal for the invention "Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer" (2021)

Impact and Influence 🌟

Prof. Dr. Özdemir's impact extends beyond research. He has held key administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School (2011-2014) and Vice Academic Director of the Anadolu University Open Education Faculty, Department of Health Administration (2015-present). His mentorship has guided many students, as evidenced by his supervision of numerous master’s and doctoral dissertations.

Legacy and Future Contributions 🚀

Prof. Dr. Özdemir’s legacy is built on his unwavering commitment to advancing pharmaceutical chemistry. His innovative research, administrative leadership, and dedication to education have left an indelible mark on Anadolu University and the broader scientific community. As he continues his work, Prof. Dr. Özdemir is poised to make further groundbreaking contributions that will shape the future of pharmaceutical sciences.

Publications

📜Title: Design, Synthesis, and Biological Evaluation of a New Series of Imidazothiazole-Hydrazone Hybrids as Dual EGFR and Akt Inhibitors for NSCLC Therapy
Authors: Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, Ahmet Özdemir
Journal: European Journal of Medicinal Chemistry
Year: 2024

📜Title: Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents
Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
Journal: ACS Omega
Year: 2024

📜Title: Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
Journal: ACS Omega
Year: 2023

📜Title: Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
Journal: ACS Omega
Year: 2023

📜Title: A New Series of Hydrazones as Small-Molecule Aldose Reductase Inhibitors
Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
Journal: Archiv der Pharmazie
Year: 2023

📜Title: A New Series of Thiazole-Hydrazone Hybrids for Akt-Targeted Therapy of Non-Small Cell Lung Cancer
Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
Journal: Drug Development Research
Year: 2023

Swayamprabha Sahoo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 16/07/202416/07/2024 by Book of Award

Mrs. Swayamprabha Sahoo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

SOA deemed to be University | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits

Mrs. Swayamprabha Sahoo began her academic journey with a Bachelor's degree in Biotechnology, graduating with distinction from the College of Basic Science and Humanities at OUAT, Bhubaneswar in 2015. She continued her education with a Master's degree in Biotechnology from the School of Pharmaceutical Science, Bhubaneswar, where she graduated with first-class honors in 2017. Her pursuit of knowledge led her to enroll in a Ph.D. program in Biotechnology at Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, which she has been undertaking since 2018.

Professional Endeavors

Mrs. Sahoo's professional experiences are rooted in her strong educational background and technical skills. She undertook significant research projects during her academic career, including her M.Sc. dissertation on the "Cloning and characterization of DMRT 1 gene in L. rohita" under the guidance of Dr. Jitendra Kumar Sundaray at ICAR-CIFA, Bhubaneswar. She also completed a six-month training at Imgenex India Pvt. Ltd. under the Biotechnology Consortium India Limited (BCIL), focusing on the expression and purification of recombinant Angiotensin converting enzyme (ACE). Additionally, she gained practical experience through a one-month training on NGS at the Institute of Bioinformatics and Applied Biotechnology (IBAB) and attended a workshop on computational biology of drug discovery through molecular docking.

Contributions and Research Focus

Mrs. Sahoo's research contributions are centered on molecular biology and bioinformatics. Her technical expertise includes primer designing, RNA isolation, gene expression analysis, recombinant protein purification, and various molecular biology techniques such as PCR, qPCR, SDS-PAGE, Western blotting, and ELISA. She has also worked extensively on bioinformatics tools like BLAST, Clustal W, and phylogenetic analysis software. Her research projects have focused on areas such as the genomic characterization and distribution of drug-resistant bacteria, which are critical for understanding and combating antibiotic resistance.

Accolades and Recognition

Throughout her academic and professional journey, Mrs. Sahoo has achieved several distinctions. She maintained a first-class academic record and was recognized for her performance in her M.Sc. and B.Sc. programs. Her research work has been published in reputable journals, and she has contributed to significant studies, including the genomic characterization of Klebsiella pneumoniae and the prevalence of multidrug-resistant organisms. Her dedication to research and her contributions to the field of biotechnology have earned her respect and recognition among her peers.

Impact and Influence

Mrs. Sahoo's work has a substantial impact on the field of biotechnology, particularly in the areas of molecular biology and bioinformatics. Her research on drug-resistant bacteria is crucial for developing new strategies to tackle antibiotic resistance, a growing global health concern. Her technical skills and knowledge contribute to advancements in molecular diagnostics and therapeutic development. Her involvement in various training programs and workshops highlights her commitment to continuous learning and skill development, which she imparts to her students and colleagues.

Legacy and Future Contributions

Mrs. Sahoo's legacy in the field of biotechnology is characterized by her dedication to research, education, and professional excellence. As she continues her Ph.D. and engages in further research, she is poised to make significant contributions to understanding and solving complex biological problems. Her future endeavors will likely focus on advancing molecular techniques and bioinformatics tools to improve health outcomes and disease management. Her work serves as an inspiration to aspiring biotechnologists and researchers, encouraging them to pursue excellence and innovation in their fields.

Notable Publications

Prevalence of multidrug-resistant Klebsiella pneumoniae in urinary tract infections: A retrospective observational study in eastern India 2024

Identification and Exploration of Transcripts Involved in Antibiotic Resistance Mechanism of Two Critical Superbugs 2024

CRISPR/Cas-Mediated Functional Gene Editing for Improvement in Bioremediation: An Emerging Strategy 2022 (5)

Quantum dots enabled point-of-care diagnostics: A new dimension to the nanodiagnosis 2022 (6)

Cheng Li | Agricultural and Biological Sciences | Best Researcher Award

Posted on 08/07/202408/07/2024 by Book of Award

Dr. Cheng Li | Agricultural and Biological Sciences | Best Researcher Award

Massachusetts Institute of Technology | United States

Author Profile

Scopus

Early Academic Pursuits

Dr. Cheng Li began his academic journey with a Bachelor of Engineering from the South China University of Technology in Guangzhou, China. His passion for biotechnology and biochemical engineering led him to pursue advanced studies at the Massachusetts Institute of Technology (MIT) in Cambridge, US, where he completed his Ph.D. in 2018. During his doctoral studies, Dr. Li focused on metabolic engineering and synthetic biology, laying a strong foundation for his future research endeavors.

Professional Endeavors

Following his Ph.D., Dr. Li embarked on a series of postdoctoral research positions. He first served as a Postdoctoral Associate at the Singapore-MIT Alliance for Research and Technology from September 2018 to March 2021. Subsequently, he continued his postdoctoral research at MIT until March 2022. His work during these years was pivotal in advancing his expertise in microbial biotechnology and metabolic engineering. In April 2022, Dr. Li was appointed as a Research Scientist at MIT, where he continues to contribute to cutting-edge research.

Contributions and Research Focus

Dr. Li's research primarily revolves around the engineering of microorganisms for the production of valuable biochemical compounds. His notable contributions include optimizing the heterologous production of α-carotene in Corynebacterium glutamicum, developing modular engineering techniques for microbial production of carotenoids, and improving recombineering techniques in Corynebacterium glutamicum. Additionally, he has explored the recycling of selectable markers in Pichia pastoris and engineered phytase expression for potential use as a feed supplement.

Accolades and Recognition

Dr. Li's work has garnered significant recognition in the scientific community. He has published extensively in high-impact journals, showcasing his innovative research in metabolic engineering and synthetic biology. Some of his prominent publications include works in Metabolic Engineering, Bioresource Technology, Biotechnology and Bioengineering, and Scientific Reports. His research on engineering carbon source division of labor for efficient α-carotene production in Corynebacterium glutamicum is particularly noteworthy.

Impact and Influence

Dr. Li's research has made substantial contributions to the field of biotechnology, particularly in the areas of metabolic engineering and synthetic biology. His innovative approaches to microbial engineering have potential applications in the production of pharmaceuticals, biofuels, and other valuable biochemicals. By advancing the efficiency and scalability of these processes, Dr. Li's work supports the development of sustainable biotechnological solutions.

Legacy and Future Contributions

As a Research Scientist at MIT, Dr. Li continues to push the boundaries of microbial biotechnology. His ongoing research aims to further refine and optimize the production of high-value compounds through microbial engineering. By mentoring the next generation of scientists and collaborating with industry partners, Dr. Li is poised to make lasting contributions to the field. His work not only addresses current scientific challenges but also paves the way for future innovations in biotechnology and synthetic biology.

Notable Publications

Expanding the CRISPR Toolbox for Engineering Lycopene Biosynthesis in Corynebacterium glutamicum 2024

Overproduction of Patchoulol in Metabolically Engineered Komagataella phaffii 2023 (7)

Guangqing Yu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 03/07/202406/07/2024 by Book of Award

Dr. Guangqing Yu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Henan Agricultural University | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Guangqing Yu began her academic journey at Henan Normal University, where she majored in aquaculture and earned a bachelor's degree in agriculture. Her interest in genetics led him to pursue a Ph.D. at the Institute of Hydrobiology, Chinese Academy of Sciences. Here, she specialized in genetics, focusing on the mechanisms of fish immune and developmental responses, laying a strong foundation for her future research.

Professional Endeavors

As an Associate Professor at Henan Agricultural University, Dr. Yu has been actively involved in both teaching and research. Her professional endeavors are marked by her leadership in various research projects, including the National Natural Science Foundation of China Youth Project and the China Postdoctoral Science Foundation's general project. She has successfully secured funding for these projects, emphasizing her capability to lead significant research initiatives.

Contributions and Research Focus

Dr. Yu's research primarily uses zebrafish as a model organism to investigate the molecular mechanisms of fish immune responses and development. Her notable contributions include elucidating the role of epigenetic modifications in fish innate immunity against viruses and embryonic development. She has also studied the biological functions of NEDD8 and its impact on the development of ovaries and secondary sexual characteristics in zebrafish. Her findings have been published in prestigious journals such as Development, Journal of Immunology, and Frontiers in Immunology.

Accolades and Recognition

Dr. Yu's work has garnered recognition in the scientific community. Her research on NEDD8 and its enhancement of Hippo signaling by mediating YAP1 neddylation has been highly respected. Additionally, her participation in the Major Research Program of the National Natural Science Foundation of China further underscores her contributions to the field.

Impact and Influence

Dr. Yu's research has significantly advanced the understanding of genetic and molecular mechanisms in fish. Her work on epigenetic modifications and their roles in immunity and development has broad implications, influencing both academic research and practical applications in aquaculture and fisheries management. Her studies on NEDD8 and androgen receptor hyperactivation have opened new avenues for understanding genetic regulation in vertebrates.

Legacy and Future Contributions

Dr. Yu's ongoing research projects and her active role in national research programs highlight her dedication to advancing the field of genetics. With multiple patents in process and numerous publications in high-impact journals, she continues to make significant contributions to molecular biology and genetics. Her future work is expected to further elucidate the complex mechanisms underlying fish biology, impacting both theoretical knowledge and practical applications.

Notable Publications

Deletion of prolyl hydroxylase domain-containing enzyme 3 (phd3) in zebrafish facilitates hypoxia tolerance 2023 (1)

Zebrafish sirt5 Negatively Regulates Antiviral Innate Immunity by Attenuating Phosphorylation and Ubiquitination of mavs 2022 (5)

Augmentation of progestin signaling rescues testis organization and spermatogenesis in zebrafish with the depletion of androgen signaling 2022 (15)

Hikari Okada | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 27/06/202427/06/2024 by Book of Award

Assoc Prof Dr. Hikari Okada | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Kanazawa University, Graduate School of Medical Sciences | Japan

Author Profile

Scopus

Early Academic Pursuits

Prof. Dr. Hikari Okada's academic journey began with a Pharm.D. from the Faculty of Pharmaceutical Sciences at Hokuriku University, Japan, in 2007. His early interest in pharmaceutical sciences led him to pursue a Master's degree in Molecular Biology at the Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan, which he completed in 2009. He further honed his expertise by obtaining a Ph.D. in Molecular Biology from the same institution in 2013.

Professional Endeavors

Dr. Okada's professional career started as a Research Associate in the Department of Gastroenterology at the Graduate School of Medical Sciences, Kanazawa University. From 2013 to 2015, he worked as a VHFJ fellow and continued his research in the same department as an AMED fellow from 2016 to 2018. He was appointed as an Assistant Professor in the Department of Integrative Medicine for Longevity at the Graduate School of Medical Sciences in 2019. Since 2022, Dr. Okada has been serving as an Associate Professor in Information-Based Medicine Development at the same institution.

Contributions and Research Focus

Dr. Okada's research primarily focuses on molecular biology, gastroenterology, and integrative medicine. His significant contributions include the study of molecular mechanisms in hepatocellular carcinoma, liver cancer stem cells, and hepatitis B and C viruses. His work on the role of Mint3 in triple-negative breast cancer and the involvement of endothelial lipase in hepatitis B virus infection has been widely recognized. Dr. Okada has published extensively, with numerous papers in high-impact journals, highlighting his commitment to advancing medical science.

Accolades and Recognition

Throughout his career, Dr. Okada has received several prestigious awards. In 2013, he was honored with the 11th Takayasu Award for Best Article and the 26th Taisyo Toyama Award, recognizing his outstanding contributions to medical research.

Impact and Influence

Dr. Okada's research has had a significant impact on the fields of molecular biology and gastroenterology. His work on cancer stem cells and viral infections has paved the way for new therapeutic approaches and improved understanding of disease mechanisms. His contributions have influenced both clinical practices and ongoing research in these areas.

Legacy and Future Contributions

Dr. Okada's legacy is marked by his dedication to research and education. His pioneering work in molecular biology and gastroenterology continues to inspire new generations of scientists and researchers. As an Associate Professor, he is actively involved in mentoring young researchers, fostering a collaborative and innovative research environment. Dr. Okada's future contributions are expected to further advance our understanding of complex diseases and lead to the development of novel therapeutic strategies.

Notable Publications

Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation 2023

Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression 2023

Functional involvement of endothelial lipase in hepatitis B virus infection 2023 (2)